-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Knockin Sequences to Program Durable Cell Therapies Acting Against Leukemia Cells

Program: Scientific Program
Session: Host Factors Driving Anti-Leukemia Immunotherapy Outcomes
Saturday, December 7, 2024, 2:00 PM-3:15 PM

Franziska Blaeschke, MD, PhD

German Cancer Research Center (DKFZ), Heidelberg, Germany

Disclosures: Blaeschke: Arsenal Bio: Patents & Royalties.

See more of: Host Factors Driving Anti-Leukemia Immunotherapy Outcomes
See more of: Scientific Program
<< Previous Presentation | Next Presentation